# Research Study to Investigate How a Study Medicine (NNC9204- 1177) Affects Blood Levels of Other Medicines in Healthy People

> **NCT04059367** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 45 (actual)

## Conditions studied

- Healthy Volunteers
- Overweight
- Obesity

## Interventions

- **DRUG:** NNC9204-1177
- **DRUG:** Cocktail of 5 already approved drugs

## Key facts

- **NCT ID:** NCT04059367
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-15
- **Primary completion:** 2020-01-02
- **Final completion:** 2020-01-02
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2020-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04059367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04059367, "Research Study to Investigate How a Study Medicine (NNC9204- 1177) Affects Blood Levels of Other Medicines in Healthy People". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04059367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*